GLP-1 improves adipose tissue glyoxalase activity and capillarization improving insulin sensitivity in type 2 diabetes
- PMID: 32942016
- DOI: 10.1016/j.phrs.2020.105198
GLP-1 improves adipose tissue glyoxalase activity and capillarization improving insulin sensitivity in type 2 diabetes
Abstract
Methylglyoxal was shown to impair adipose tissue capillarization and insulin sensitivity in obese models. We hypothesized that glyoxalase-1 (GLO-1) activity could be diminished in the adipose tissue of type 2 diabetic obese patients. Moreover, we assessed whether such activity could be increased by GLP-1-based therapies in order to improve adipose tissue capillarization and insulin sensitivity. GLO-1 activity was assessed in visceral adipose tissue of a cohort of obese patients. The role of GLP-1 in modulating GLO-1 was assessed in type 2 diabetic GK rats submitted to sleeve gastrectomy or Liraglutide treatment, in the adipose tissue angiogenesis assay and in the HUVEC cell line. Glyoxalase-1 activity was decreased in visceral adipose tissue of pre-diabetic and diabetic obese patients, together with other markers of adipose tissue dysfunction and correlated with increased HbA1c levels. Decreased adipose tissue GLO-1 levels in GK rats were increased by sleeve gastrectomy and Liraglutide, being associated with overexpression of angiogenic and vasoactive factors, as well as insulin receptor phosphorylation (Tyr1161). Moreover, GLP-1 increased adipose tissue capillarization and HUVEC proliferation in a glyoxalase-dependent manner. Lower adipose tissue GLO-1 activity was observed in dysmetabolic patients, being a target for GLP-1 in improving adipose tissue capillarization and insulin sensitivity.
Keywords: Adipose tissue; Capillarization; GLP-1; Glyoxalase; Insulin resistance; Liraglutide.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Similar articles
-
Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats.Clin Exp Nephrol. 2021 Apr;25(4):365-375. doi: 10.1007/s10157-020-02007-2. Epub 2021 Jan 6. Clin Exp Nephrol. 2021. PMID: 33409761
-
Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet.Cardiovasc Diabetol. 2020 Feb 24;19(1):24. doi: 10.1186/s12933-020-01000-z. Cardiovasc Diabetol. 2020. PMID: 32093680 Free PMC article.
-
Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.Diabetes. 2018 Aug;67(8):1504-1511. doi: 10.2337/db18-0081. Epub 2018 May 14. Diabetes. 2018. PMID: 29759973 Free PMC article.
-
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome.Curr Vasc Pharmacol. 2017;15(3):218-229. doi: 10.2174/1570161114666161221115324. Curr Vasc Pharmacol. 2017. PMID: 28003008 Review.
-
Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.Am J Health Syst Pharm. 2019 Oct 15;76(21):1739-1748. doi: 10.1093/ajhp/zxz179. Am J Health Syst Pharm. 2019. PMID: 31612934 Review.
Cited by
-
The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials.Diabetol Metab Syndr. 2023 Jul 26;15(1):164. doi: 10.1186/s13098-023-01118-6. Diabetol Metab Syndr. 2023. PMID: 37491292 Free PMC article.
-
PHPB Attenuated Cognitive Impairment in Type 2 Diabetic KK-Ay Mice by Modulating SIRT1/Insulin Signaling Pathway and Inhibiting Generation of AGEs.Pharmaceuticals (Basel). 2023 Feb 15;16(2):305. doi: 10.3390/ph16020305. Pharmaceuticals (Basel). 2023. PMID: 37259448 Free PMC article.
-
Are gut dysbiosis, barrier disruption, and endotoxemia related to adipose tissue dysfunction in metabolic disorders? Overview of the mechanisms involved.Intern Emerg Med. 2023 Aug;18(5):1287-1302. doi: 10.1007/s11739-023-03262-3. Epub 2023 Apr 4. Intern Emerg Med. 2023. PMID: 37014495 Free PMC article. Review.
-
Exposure to Obesogenic Environments during Perinatal Development Modulates Offspring Energy Balance Pathways in Adipose Tissue and Liver of Rodent Models.Nutrients. 2023 Mar 4;15(5):1281. doi: 10.3390/nu15051281. Nutrients. 2023. PMID: 36904281 Free PMC article.
-
Circulating Dopamine Is Regulated by Dietary Glucose and Controls Glucagon-like 1 Peptide Action in White Adipose Tissue.Int J Mol Sci. 2023 Jan 27;24(3):2464. doi: 10.3390/ijms24032464. Int J Mol Sci. 2023. PMID: 36768789 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
